157 related articles for article (PubMed ID: 10388483)
1. Stereospecific analysis and enantiomeric disposition of 3, 4-methylenedioxymethamphetamine (Ecstasy) in humans.
Fallon JK; Kicman AT; Henry JA; Milligan PJ; Cowan DA; Hutt AJ
Clin Chem; 1999 Jul; 45(7):1058-69. PubMed ID: 10388483
[TBL] [Abstract][Full Text] [Related]
2. Optical isomer analysis of 3,4-methylene-dioxyamphetamine analogues and their stereoselective disposition in rats.
Matsushima K; Nagai T; Kamiyama S
J Anal Toxicol; 1998; 22(1):33-9. PubMed ID: 9491966
[TBL] [Abstract][Full Text] [Related]
3. Determination of MDMA and its metabolites in blood and urine by gas chromatography-mass spectrometry and analysis of enantiomers by capillary electrophoresis.
Pizarro N; Ortuño J; Farré M; Hernández-López C; Pujadas M; Llebaria A; Joglar J; Roset PN; Mas M; Segura J; Camí J; de la Torre R
J Anal Toxicol; 2002 Apr; 26(3):157-65. PubMed ID: 11991532
[TBL] [Abstract][Full Text] [Related]
4. Distribution of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) stereoisomers in a fatal poisoning.
Moore KA; Mozayani A; Fierro MF; Poklis A
Forensic Sci Int; 1996 Dec; 83(2):111-9. PubMed ID: 9022274
[TBL] [Abstract][Full Text] [Related]
5. Arginine vasopressin release in response to the administration of 3,4-methylenedioxymethamphetamine ("ecstasy"): is metabolism a contributory factor?
Forsling M; Fallon JK; Kicman AT; Hutt AJ; Cowan DA; Henry JA
J Pharm Pharmacol; 2001 Oct; 53(10):1357-63. PubMed ID: 11697543
[TBL] [Abstract][Full Text] [Related]
6. Analysis of 3,4-methylenedioxymethamphetamine (MDMA) and its metabolites in plasma and urine by HPLC-DAD and GC-MS.
Helmlin HJ; Bracher K; Bourquin D; Vonlanthen D; Brenneisen R
J Anal Toxicol; 1996 Oct; 20(6):432-40. PubMed ID: 8889680
[TBL] [Abstract][Full Text] [Related]
7. Drug testing in blood: validated negative-ion chemical ionization gas chromatographic-mass spectrometric assay for enantioselective measurement of the designer drugs MDEA, MDMA, and MDA and its application to samples from a controlled study with MDMA.
Peters FT; Samyn N; Lamers CT; Riedel WJ; Kraemer T; de Boeck G; Maurer HH
Clin Chem; 2005 Oct; 51(10):1811-22. PubMed ID: 16099938
[TBL] [Abstract][Full Text] [Related]
8. Non-linear pharmacokinetics of MDMA ('ecstasy') in humans.
de la Torre R; Farré M; Ortuño J; Mas M; Brenneisen R; Roset PN; Segura J; Camí J
Br J Clin Pharmacol; 2000 Feb; 49(2):104-9. PubMed ID: 10671903
[TBL] [Abstract][Full Text] [Related]
9. Plasma pharmacokinetics of 3,4-methylenedioxymethamphetamine after controlled oral administration to young adults.
Kolbrich EA; Goodwin RS; Gorelick DA; Hayes RJ; Stein EA; Huestis MA
Ther Drug Monit; 2008 Jun; 30(3):320-32. PubMed ID: 18520604
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic profile of single and repeated oral doses of MDMA in squirrel monkeys: relationship to lasting effects on brain serotonin neurons.
Mechan A; Yuan J; Hatzidimitriou G; Irvine RJ; McCann UD; Ricaurte GA
Neuropsychopharmacology; 2006 Feb; 31(2):339-50. PubMed ID: 15999148
[TBL] [Abstract][Full Text] [Related]
11. Sprague-Dawley rats display sex-linked differences in the pharmacokinetics of 3,4-methylenedioxymethamphetamine (MDMA) and its metabolite 3,4-methylenedioxyamphetamine (MDA).
Fonsart J; Menet MC; Debray M; Hirt D; Noble F; Scherrmann JM; Declèves X
Toxicol Appl Pharmacol; 2009 Dec; 241(3):339-47. PubMed ID: 19781562
[TBL] [Abstract][Full Text] [Related]
12. Analysis of MDMA and its metabolites in urine and plasma following a neurotoxic dose of MDMA.
Valtier S; Phelix CF; Cody JT
J Anal Toxicol; 2007 Apr; 31(3):138-43. PubMed ID: 17579960
[TBL] [Abstract][Full Text] [Related]
13. Hair analysis for drug abuse. XV. Disposition of 3, 4-methylenedioxymethamphetamine (MDMA) and its related compounds into rat hair and application to hair analysis for MDMA abuse.
Kikura R; Nakahara Y; Mieczkowski T; Tagliaro F
Forensic Sci Int; 1997 Jan; 84(1-3):165-77. PubMed ID: 9042722
[TBL] [Abstract][Full Text] [Related]
14. Stereoselective urinary MDMA (ecstasy) and metabolites excretion kinetics following controlled MDMA administration to humans.
Schwaninger AE; Meyer MR; Barnes AJ; Kolbrich-Spargo EA; Gorelick DA; Goodwin RS; Huestis MA; Maurer HH
Biochem Pharmacol; 2012 Jan; 83(1):131-8. PubMed ID: 21983032
[TBL] [Abstract][Full Text] [Related]
15. Stereochemical analysis of 3,4-methylenedioxymethamphetamine and its main metabolites in human samples including the catechol-type metabolite (3,4-dihydroxymethamphetamine).
Pizarro N; Farré M; Pujadas M; Peiró AM; Roset PN; Joglar J; de la Torre R
Drug Metab Dispos; 2004 Sep; 32(9):1001-7. PubMed ID: 15319342
[TBL] [Abstract][Full Text] [Related]
16. Distribution of methylenedioxymethamphetamine (MDMA) and methylenedioxyamphetamine (MDA) in postmortem and antemortem specimens.
Liu RH; Liu HC; Lin DL
J Anal Toxicol; 2006 Oct; 30(8):545-50. PubMed ID: 17132249
[TBL] [Abstract][Full Text] [Related]
17. Enantioselective metabolism of the designer drugs 3,4-methylenedioxymethamphetamine ('ecstasy') and 3,4-methylenedioxyethylamphetamine ('eve') isomers in rat brain and blood.
Meyer A; Mayerhofer A; Kovar KA; Schmidt WJ
Neurosci Lett; 2002 Sep; 330(2):193-7. PubMed ID: 12231444
[TBL] [Abstract][Full Text] [Related]
18. Contribution of cytochrome P450 2D6 to 3,4-methylenedioxymethamphetamine disposition in humans: use of paroxetine as a metabolic inhibitor probe.
Segura M; Farré M; Pichini S; Peiró AM; Roset PN; Ramírez A; Ortuño J; Pacifici R; Zuccaro P; Segura J; de la Torre R
Clin Pharmacokinet; 2005; 44(6):649-60. PubMed ID: 15910012
[TBL] [Abstract][Full Text] [Related]
19. Gas chromatographic/mass spectrometric assay for profiling the enantiomers of 3,4-methylenedioxymethamphetamine and its chiral metabolites using positive chemical ionization ion trap mass spectrometry.
de Boer D; Tan LP; Gorter P; van de Wal RM; Kettenes-van den Bosch JJ; de Bruijn EA; Maes RA
J Mass Spectrom; 1997 Nov; 32(11):1236-46. PubMed ID: 9373962
[TBL] [Abstract][Full Text] [Related]
20. Urinary MDMA, MDA, HMMA, and HMA excretion following controlled MDMA administration to humans.
Abraham TT; Barnes AJ; Lowe RH; Kolbrich Spargo EA; Milman G; Pirnay SO; Gorelick DA; Goodwin RS; Huestis MA
J Anal Toxicol; 2009 Oct; 33(8):439-46. PubMed ID: 19874650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
